A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

All had locally advanced cervical cancer, although none had tumors that had spread to other organs. The control group ...

Three prospective randomized trials comparing the efficacy of preoperative and postoperative chemoradiotherapy in locally advanced rectal cancer were initiated between 1993 and 1994. 4,5 Two of ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Read more about A trial looking at a drug called UCB4594 for cancer that has spread A trial looking at tolinapant and chemoradiotherapy for cervical cancer that has spread (CRAIN) This trial is ...

Keytruda (pembrolizumab) has been approved for use in combination with chemoradiotherapy (CRT) for patients with high-risk locally advanced cervical cancer; in other words, those with stage III to ...

During the past 20 years, the advent of neoadjuvant, primary, and adjuvant concurrent chemoradiotherapy has improved cancer care dramatically. Significant contributions have been made by ...

Merck (NYSE:MRK) announced Friday that its anti-PD1 immunotherapy Keytruda, in combination with chemoradiotherapy ... high-risk locally advanced cervical cancer patients who received Keytruda ...

Ms Ingham underwent chemoradiotherapy and brachytherapy ... and hope that this can be done as quickly as possible." Cervical Cancer Prevention Week runs until January 28.